Abstract
Patients affected by diabetes have a higher rate of hospitalization and mortality after a SARS-CoV-2 infection. Diabetes is indeed a negative prognostic factor for coronavirus disease 2019 (COVID-19) and can increase its risk of severity and mortality by more than two times. Furthermore, although on one hand people with diabetes are more at risk of developing complications from COVID-19, the SARS-CoV-2 infection could also act as a diabetic agent by binding to ACE2 in the pancreatic beta-cells and causing their acute dysfunction. To date, there are few data on the impact of the COVID-19 disease on the onset of insulin-dependent diabetes in adult patients. We evaluated the pathophysiological mechanisms binding COVID-19 and diabetes mellitus by discussing the clinical case of a 47-year-old woman admitted to the intensive care unit for coma due to diabetic ketoacidosis secondary to SARS-CoV-2 infection. The patient was successfully treated with acute rehydration, normalization of glycemia, and chronic administration of insulin to maintain normal blood glucose levels.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020;18(9):2128–2130.e2.
Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(S27):155–77.
Merger SR, Leslie RD, Boehm BO. The broad clinical phenotype of type 1 diabetes at presentation. Diabet Med. 2013;30(2):170–8.
Ji J, Sundquist J, Sundquist K. Association between anorexia nervosa and type 2 diabetes in Sweden: etiological clue for the primary prevention of type 2 diabetes. Endocr Res. 2016;41(4):310–6.
Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr. 2020;14(4):535–45.
Chambers MA, Mecham C, Arreola EV, Sinha M. Increase in the number of pediatric new-onset diabetes and diabetic ketoacidosis cases during the COVID-19 pandemic. Endocr Pract. 2022;28(5):479–85.
Acknowledgments
We would like to acknowledge the medical staff working at Sant’Anna Hospital’s university ICU, in Ferrara (Italy), for their daily passion and dedication to take care of both COVID-19 and non-COVID-19 critically ill patients.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bussolati, E., Ferrara, D., Scaramuzzo, G. (2023). Diabetes Ketoacidosis: New Onset Diabetes with Diabetic Ketoacidosis After SARS-CoV-2 Infection in Adult Critically Ill Patient. In: Pérez-Torres, D., MartÃnez-MartÃnez, M., Schaller, S.J. (eds) Best 2022 Clinical Cases in Intensive Care Medicine. Lessons from the ICU. Springer, Cham. https://doi.org/10.1007/978-3-031-36398-6_54
Download citation
DOI: https://doi.org/10.1007/978-3-031-36398-6_54
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-36397-9
Online ISBN: 978-3-031-36398-6
eBook Packages: MedicineMedicine (R0)